EUCLORINA POLV SOL 10BUST 2.5G

EUCLORINA 2.5 G SOLUBLE POWER

active ingredients

Each bag contains: Active ingredient: Chloramine 2.5 g

Excellent

Nobody

Therapeutic indications

Euclorine soluble powder is used for washing and packing in: - Disinfection of the skin and treatment of small superficial lesions, abrasions, decubitate wounds with limited interest to the epidermis. - Disinfection of external genitals.

Contraindications

Hypersensitivity to the active ingredient, to other substances strictly related to the chemical or to any of the excipients listed in the paragraph 6.1.

Population

• Disinfection and cleaning of the skin: 4 sachets in 1 liter of water (or 1 sachet in 250 ml of water). • Disinfection of external genitals: 1 bag in 1 liter of water. 1 application subject to different medical assessment.

Conservation

Store at a temperature below 30°C

Warnings

Don't swallow. The product is only for external use. Ingestion or accidental inhalation of some disinfectants may have serious, sometimes fatal consequences. Prolonged use of these products with topical application can give rise to awareness phenomena; in this case, you must stop the treatment and consult your doctor to educate a suitable therapy. Do not use for prolonged treatments. After a short period of treatment without appreciable results consult your doctor. Do not use the medicine after the expiry date indicated on the package. TENERE THE MEDICINAL FUORI FROM THE PORTED OF CHILDREN.

Interactions

Avoid the contemporary use of other antiseptics and detergents

Effects

It is possible to occur, in some cases, of intolerance (burning or irritation) that does not require modification of the treatment. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

No one known

In pregnant women and during breastfeeding, the medicine should be administered in case of actual need and under direct medical control.

Source: Farmadati